- Roivant Sciences (NASDAQ:ROIV) on Wednesday announced that it has commenced an underwritten public offering of $150 million of common shares.
- Roivant expects to grant the underwriters a 30-day option to purchase up to an additional $22.5 million of common shares.
- All of the common shares are being offered by Roivant.
- Goldman Sachs, SVB Securities, Cowen, and Cantor Fitzgerald are acting as bookrunning managers for the offering.
- Shares -4.7% after hours.
Roivant launches $150M stock offering, shares fall
Recommended For You
About ROIV Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| ROIV | - | - |
| Roivant Sciences Ltd. | ||